Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ribulose-5-Phosphate (Ru5P) is a key five-carbon sugar phosphate that serves as a central intermediate in several metabolic pathways, including the pentose phosphate pathway (PPP) and the Calvin-Benson cycle. It is crucial for the biosynthesis of various essential biomolecules, such as riboflavin (vitamin B2), NADPH (a reducing equivalent vital for anabolic reactions and antioxidant defense), and nucleotides. Its metabolic flux is often engineered in microorganisms like *Escherichia coli* to enhance the production of valuable compounds. It also plays a role in regulating cellular processes, including lipogenesis and cell proliferation, and its levels can be altered in disease states like prostate cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ribulose-5-Phosphate.